InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in InflaRx N.V. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −4 vs. Q1 2024
- Shares held
- 13.2M
- −629.1K (−4.5%) vs. Q1 2024
- Total value
- $23.0M
- +$1.67M (+7.8%) vs. Q1 2024
- New holders
- 4
- 8 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 449 | $0 | 0.00% | +148+49.2% | Added |
| JPMorgan Chase & Co | 58 | $101 | 0.00% | +58 | New |
| Qube Research & Technologies Ltd | 770 | $1.34K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 795 | $1.38K | 0.00% | +795 | New |
| Citigroup Inc | 1,301 | $2.26K | 0.00% | −1,200,000−99.9% | Reduced |
| GWM Advisors LLC | 1,400 | $2.44K | 0.00% | 00.0% | Unchanged |
| Wetzel Investment Advisors, Inc. | 2,000 | $3.08K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 4,800 | $8.35K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8,700 | $15.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,070 | $21.0K | 0.00% | +12,070 | New |
| Toroso Investments, LLC | 13,057 | $22.7K | 0.00% | −2,096−13.8% | Reduced |
| Pacifica Partners Inc. | 20,585 | $33.6K | 0.01% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 20,100 | $35.0K | 0.00% | −5,600−21.8% | Reduced |
| BNP Paribas Arbitrage, SA | 22,300 | $38.8K | 0.00% | +1,020+4.8% | Added |
| Squarepoint Ops LLC | 25,072 | $43.6K | 0.00% | +8,207+48.7% | Added |
| Marshall Wace, LLP | 33,824 | $58.9K | 0.00% | −47,995−58.7% | Reduced |
| Northern Trust Corp | 33,890 | $59.0K | 0.00% | −768−2.2% | Reduced |
| Geode Capital Management, LLC | 36,236 | $63.0K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 50,000 | $87.0K | 0.08% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 51,541 | $89.7K | 0.00% | −50,674−49.6% | Reduced |
| Citadel Advisors LLC | 62,425 | $108.6K | 0.00% | −35,559−36.3% | Reduced |
| Franklin Street Advisors Inc | 75,100 | $131.0K | 0.01% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 102,500 | $178.0K | 0.00% | +32,500+46.4% | Added |
| Boothbay Fund Management, LLC | 158,035 | $275.0K | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 173,586 | $302.0K | 0.00% | +173,586 | New |
| Raymond James & Associates | 291,849 | $507.8K | 0.00% | +49,229+20.3% | Added |
| Raymond James Financial Services Advisors, Inc. | 376,914 | $655.8K | 0.00% | −8,058−2.1% | Reduced |
| Ikarian Capital, LLC | 704,987 | $1.23M | 0.38% | 00.0% | Unchanged |
| UBS Oconnor LLC | 721,768 | $1.26M | 0.04% | +339,359+88.7% | Added |
| Morgan Stanley | 827,831 | $1.44M | 0.00% | −150,690−15.4% | Reduced |
| Eversept Partners, LP | 1,566,930 | $2.73M | 0.21% | +261,790+20.1% | Added |
| 683 Capital Management, LLC | 2,070,000 | $3.60M | 0.38% | +1,200,000+137.9% | Added |
| Suvretta Capital Management, LLC | 5,733,910 | $9.98M | 0.41% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −769,065−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −194,465−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −139,957−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −46,515−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,153−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −12,534−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,251−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,466−100.0% | Sold out |